Home > Press > Acquisition of Corporate Scientific Claisse Inc.
Acquisition of Corporate Scientific Claisse Inc. |
Abstract:
Spectris plc (‘Spectris' or the ‘Company') (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that it has acquired the business and assets of the Canadian company La Corporation Scientifique Claisse Inc. (‘Claisse'), a global market leader in sample preparation for atomic spectroscopy (including X-ray) analysis, for an undisclosed sum. Revenues for the year ending March 2014 were CAD 13 million.
Claisse designs, manufactures and sells consumables and instruments used to prepare consistent and comparable samples for spectroscopic analysis in mining, pharmaceutical, academic research and industrial applications. Claisse will become part of the Materials Analysis segment and will be integrated into PANalytical, combining two leaders in fusion and X-ray fluorescence (XRF) analysis.
Eoghan O'Lionaird, Spectris Business Group Director, said: "Claisse is a strong strategic addition to Spectris' Materials Analysis segment as it deepens our presence within the sample preparation market. Claisse is renowned for its innovation and fusion technology leadership, and we are confident that the market will benefit from PANalytical's support of Claisse's continued product and application development plans. We believe there is a strong cultural fit with PANalytical, and that the combined capabilities will create significant value for our XRF customers, as well as increasing PANalytical's resilient revenues."
####
About PANalytical
PANalytical’s mission is to enable people to get valuable insight into their materials and processes. Our customers can be found in virtually every industry segment, from building materials to pharmaceuticals and from metals and mining to nanomaterials. The combination of our software and instrumentation, based on X-ray diffraction (XRD), X-ray fluorescence (XRF), near-infrared (NIR) and optical emission (OES) spectroscopy and pulsed fast thermal neutron activation (PFTNA), provides our customers with highly reliable and robust elemental and structural information on their materials and is applied in scientific research and industrial process and quality control.
PANalytical employs over 1,000 people worldwide. The company’s headquarters are in Almelo, the Netherlands. Fully equipped application laboratories are established in Japan, China, the US, Brazil, and the Netherlands. PANalytical’s research activities are based in Almelo (NL) and on the campus of the University of Sussex in Brighton (UK). Supply and competence centers are located on two sites in the Netherlands: Almelo (development and production of X-ray instruments) and Eindhoven (development and production of X-ray tubes), in Nottingham, UK (development of XRF applications and standards) and in Boulder CO, US (development and production of near-infrared instruments).
PANalytical is active in all but a few countries of the world. This worldwide sales and service network ensures unrivalled levels of customer support.
The company is certified in accordance with ISO 9001 and ISO 14001.
Visit www.panalytical.com for more information about our activities.
PANalytical is part of Spectris plc, the productivity-enhancing instrumentation and controls company.
For more information, please click here
Contacts:
PANalytical
Pieter de Groot, Corporate Marketing Director
T +31 546 534444
F +31 546 534598
Copyright © PANalytical
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Imaging
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Acquisitions/Mergers/Splits
180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020
180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020
Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||